首页 | 本学科首页   官方微博 | 高级检索  
     

胃癌前病变与幽门螺杆菌关系随访研究
引用本文:周季英,邝小枫,黄静薇,胡陆林. 胃癌前病变与幽门螺杆菌关系随访研究[J]. 东南大学学报(医学版), 1999, 0(2)
作者姓名:周季英  邝小枫  黄静薇  胡陆林
作者单位:广州铁路集团公司中心医院消化内科,广州铁路集团公司中心医院病理科
基金项目:广州铁路集团公司科技发展计划
摘    要:目的:探讨胃癌前病变病理改变的性质、程度和幽门螺杆菌(HP)感染及药物治疗与其变化过程的关系。方法:胃镜活检慢性萎缩性胃炎(萎缩)37例,伴肠上皮化生(肠化)19例、不典型增生7例,观察其与HP关系,HP以Gimesa染色,肠化者以粘液组织化学染色。19例萎缩伴肠化服德诺28d加施尔康6个月,HP阳性者加阿莫西林14d治疗,常规胃镜查HP根除率。随访6~31.5个月复查胃镜及HP。结果:萎缩、肠化、不典型增生HP阳性率分别为86.5%(32/37)、78.9%(15/19)和57.1%(4/7)。19例萎缩伴肠化HP根除率为66.7%(10/15),萎缩、炎症、肠化改善有效率分别为63.2%(12/19)、73.7%(14/19)和78.9%(15/19)。其中已根除HP者分别占66.7%(8/12)、71.4%(10/14)和66.7%(10/15),与未根除HP者炎症与肠化改善例数比较有显著性差异(P<0.01)。结论:胃癌前病变与HP关系密切,联合抗HP药物及多种维生素疗法对改善胃癌前病变有效。

关 键 词:螺杆菌.幽门;慢性萎缩性胃炎;肠上皮化生;不典型增生

A Followup Study of Relationship between Gastric Cancer and Helicobacter Pylori
Zhou Jiying,Kuang Xiaofeng,Huang Jingwei,Hu Lulin. A Followup Study of Relationship between Gastric Cancer and Helicobacter Pylori[J]. Journal of Southeast Univ: Medical Sci Ed, 1999, 0(2)
Authors:Zhou Jiying  Kuang Xiaofeng  Huang Jingwei  Hu Lulin
Abstract:bjective: The purpose of the study was to investigate the relationship between gastric precancerous change and Helicobacter pylori (HP). Methods: Thirtyseven patients with chronic atrophic gastritis(CAG),19 cases of CAG with intestinal metaplasia(IM) and 7 cases with atypical hyperplasia were biopsyed by endoscopy to observe their correlation with HP.The HP positive specimens were stained with Gimesa's dyeing, and the sections from patients with IM were examined with mucus histochemistry dye.Ninteen cases of CAG with IM were treated Denol for 28 days and TheragraM for 6 months.The HP( ) cases were added with Amoxycillin remedy for 14 days.HP eradication was examined by regular endoscopy.The patients were counterchecked by endoscopy and HP at the followup of 631.5 months. Results: The HP positive rate of patients with CAG,IM and atypical hyperplasia was found to be 86.5%(32/37),78.9%(15/19) and 57.1%(4/7),respectively.The HP eradication in 19 cases of CAG with intestinal epidermis was detected in 10 of 15 (66.7%). The effective rate of improvement of atrophy, inflammation and IM was found to be 63.2% (12/19), 73.7% (14/19) and 78.9%(15/19),respectively.The HP eradication rate was found to be 66.7%(8/12), 71.4%(10/14) and 66.7%(10/15),respectively.These values are of significance(P<0.01) in comparison with those from noneradication group. Conclusions: There is a close relationship between gastric precancerous changes and HP.The combined therapy of antiHP drugs with multivitamins is effective to improve gastric precancerous changes.
Keywords:Helicobacter pylori  chronic atrophic gastritis  intestinal metaplasia  atypical hyperplasia
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号